Paris Cardiovascular Research Centre, INSERM U970, Paris, France; Université Paris-Saclay, Matériaux et santé, 92296, Châtenay-Malabry, France.
Université Paris-Saclay, Matériaux et santé, 92296, Châtenay-Malabry, France; Department of Pharmacy, Pitié-Salpêtrière Hospital, AP-HP, Paris, France.
J Pharm Biomed Anal. 2021 Mar 20;196:113934. doi: 10.1016/j.jpba.2021.113934. Epub 2021 Feb 2.
Umifenovir is an antiviral drug approved in China and Russia for the treatment of influenza. The available dosage form consists of capsules marketed under the brand name Arbidol®. Due to its broad spectrum, umifenovir may also be used in other viral contexts, alone or combined with other antiviral drugs. Although knowledge of umifenovir intrinsic stability may be useful for any potential development of other pharmaceutical forms for other routes of administration and for quality risk management, no data regarding this matter is available to date. In this study, the exploration of the molecule's behaviour under hydrolytic, oxidative and photolytic conditions was carried out experimentally and supported by density functional theory (DFT) studies. It comes out that umifenovir is sensitive to these stress conditions giving rise to 6 structurally characterized degradation products. The one-electron oxidation process produced on the sulphur atom is probably the main cause of umifenovir degradation with reference to the structures of the degradation products formed and the DFT data.
乌米酚韦是一种在中国和俄罗斯获得批准的抗病毒药物,用于治疗流感。现有的剂型为胶囊,以商品名 Arbidol®上市。由于其广谱性,乌米酚韦也可能单独或与其他抗病毒药物一起用于其他病毒感染情况。尽管了解乌米酚韦的固有稳定性对于任何其他潜在的给药途径的其他剂型的开发和质量风险管理可能是有用的,但迄今为止,尚无关于这方面的数据。在这项研究中,通过实验和密度泛函理论(DFT)研究探索了分子在水解、氧化和光解条件下的行为。结果表明,乌米酚韦对这些应激条件敏感,生成了 6 种结构特征明确的降解产物。参考形成的降解产物的结构和 DFT 数据,硫原子上的单电子氧化过程可能是乌米酚韦降解的主要原因。